Skip to main content
Avivagen Inc. logo

Avivagen Inc. — Investor Relations & Filings

Ticker · VIV ISIN · CA05382F2026 TSXV Manufacturing
Open in API
Filings indexed 552 across all filing types
Latest filing 2022-03-23 Regulatory Filings
Country CA Canada
Listing TSXV VIV

About Avivagen Inc.

http://www.avivagen.com

Avivagen Inc. was a life sciences corporation focused on developing and commercializing natural health products for livestock, companion animals, and humans. The company specialized in feed additives designed to support immune function and promote growth in animals, emphasizing science-based validation through clinical trials. On April 23, 2024, Avivagen Inc. filed a voluntary assignment in bankruptcy, and a trustee was appointed to manage the proceedings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2022-03-23 English
News release - English.pdf
Regulatory Filings
2022-03-22 English
News release - English.pdf
Regulatory Filings
2022-03-08 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of availability of proxy materials for Avivagen Inc.'s Annual General Meeting (AGM). It provides information on how to access the proxy materials and instructions for voting, but does not contain the proxy materials themselves or detailed meeting content. The document is short (3117 characters) and serves as an announcement directing shareholders to the full materials online. According to the 'Menu vs Meal' rule, such a notice is classified as a Proxy Solicitation & Information Statement (PSI) or possibly an RPA if it were announcing a report publication. However, since it specifically relates to proxy materials for an AGM and includes voting instructions, the best fit is Proxy Solicitation & Information Statement (PSI).
2022-02-28 English
Management information circular - English.pdf
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS' and includes detailed information about the upcoming AGM, including the date, location, agenda items such as receiving financial statements, electing directors, appointing auditors, and proxy voting instructions. It also references the Management Information Circular related to the AGM. The document does not contain the actual financial statements or detailed financial performance data but rather serves as a notice and proxy solicitation for the AGM. Therefore, it is not an Annual Report (10-K) or Management Report (MDA), but a notice and related materials for the AGM. This fits the definition of AGM Information (AGM-R). The document length is substantial and contains detailed AGM-related information, confirming the classification with high confidence.
2022-02-28 English
Notice of meeting - English.pdf
AGM Information Classification · 100% confidence The document is a Notice of Annual General Meeting (AGM) of shareholders for Avivagen Inc. It details the date, time, location, and agenda of the AGM, including receiving financial statements, electing directors, appointing auditors, and other business. It also references the availability of proxy materials and related documents online. The document does not contain the actual financial statements or detailed reports but serves as a formal notice to shareholders about the upcoming AGM and voting procedures. Therefore, it fits the category of AGM Information (AGM-R). The document length is about 5,496 characters, which is consistent with a notice rather than a full report.
2022-02-28 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.